Horizon Therapeutics Public Ltd Co

GOLDMAN SACHS GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

5/15/2024

Shares

698,361

Value ($000)

80,793

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	5/15/2024	80,793	0.0%	698,361	9/30/2023
2023 Q2	5/14/2024	46,912	0.0%	456,117	6/30/2023
2023 Q1	5/14/2024	53,425	0.0%	489,505	3/31/2023
2022 Q4	5/14/2024	94,786	0.0%	832,914	12/31/2022
2022 Q3	5/14/2024	96,500	0.0%	1,559,201	9/30/2022
2022 Q2	5/14/2024	125,281	0.0%	1,570,717	6/30/2022
2022 Q1	5/16/2022	161,135	0.0%	1,531,545	3/31/2022
2021 Q4	2/17/2022	78,129	0.0%	725,028	12/31/2021
2021 Q3	1/20/2022	72,745	0.0%	664,100	9/30/2021
2021 Q2	8/13/2021	62,852	0.0%	671,206	6/30/2021
2021 Q1	5/17/2021	119,224	0.0%	1,295,347	3/31/2021
2020 Q4	2/12/2021	69,280	0.0%	947,096	12/31/2020
2020 Q3	11/13/2020	74,891	0.0%	964,094	9/30/2020
2020 Q2	8/12/2020	111,583	0.0%	2,007,625	6/30/2020
2020 Q1	5/15/2020	32,791	0.0%	1,107,081	3/31/2020
2019 Q4	2/14/2020	17,881	0.0%	493,957	12/31/2019